Post-earnings recap
Reported
Thu, Apr 30, 2026
EPS actual
$1.33
EPS est.
$1.33
EPS surprise
+0.00%
1-day move
-6.76%
Balchem Corporation reported earnings that matched expectations for EPS, but there was no revenue figure provided. The stock reacted negatively, dropping 6.76%, which may indicate investor concerns about future performance or the lack of revenue guidance. Without additional context from management, it's difficult to assess the company's outlook.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.33 | $1.33 | +0.00% |
| Revenue | N/A | $267M | N/A |
No transcript is on record, so the analysis is based solely on numerical results.
Balchem Corporation (BCPC) operates in the specialty chemicals sector, focusing on producing and marketing innovative solutions for various industries, including food, pharmaceuticals, and agriculture. With a market cap of $6 billion, the company plays a crucial role in providing essential materials that enhance product performance and safety.
Last quarter
In Q4-2025, Balchem reported an EPS of $1.31, exceeding estimates by 1.95%. However, the stock reacted negatively, declining by 2.11% the following day.
EPS beat streak
1Q
EPS beat rate
63%
Avg EPS surprise
+2.40%
Avg 1-day reaction
+0.06%
Analysts expect Balchem to report solid earnings this quarter, with a consensus EPS of $1.33. Investors will be closely watching for any updates on revenue growth and market conditions.
Bull case
If Balchem beats earnings expectations, it could signal strong demand for its products and lead to a positive stock reaction, potentially boosting investor confidence.
Bear case
On the other hand, if the company misses its earnings target, it may raise concerns about market demand and profitability, leading to a decline in stock price.
Key metrics to watch
EPS
$1.33Earnings per share is a key indicator of the company's profitability and financial health.
Revenue
$267MRevenue figures provide insight into the company's sales performance and market demand.
The print will turn on these.
Q1
Will Balchem's EPS exceed the consensus estimate of $1.33?
A beat on EPS would indicate stronger profitability and could positively impact investor sentiment.
Q2
What are the revenue figures compared to the consensus of $267M?
Revenue performance is critical for assessing market demand and overall business health.
—
Est. EPS
$1.21
Est. Rev
$34.9B
Impl. Move
±5.2%
Why consensus could be wrong
The consensus may be underestimating Balchem's ability to leverage its innovative product lines, which could drive revenue growth beyond expectations.
Supporting evidence
Balchem has consistently beaten EPS estimates in 75% of the last eight quarters.
The options market is pricing a larger move than historical averages, suggesting potential for a significant surprise.
Key risk
If revenue significantly exceeds $267M, it could challenge the current bearish sentiment.
Pre-commit to what would confirm each case.
This quarter's performance will hinge on whether Balchem can meet or exceed expectations in a challenging market environment.
Bull confirmed if
An EPS of $1.35 or higher would confirm the bull case, indicating strong operational performance.
Bear confirmed if
An EPS below $1.30 would confirm the bear case, raising concerns about profitability.
What the market is pricing for the move.
Implied Move
±2.91%
Historical Avg
±2.9%
The options market is pricing in a move of nearly 3% around the earnings report, indicating some uncertainty among investors.
Options are pricing ±2.9% while BCPC has averaged ±2.9% over the last 8 prints — setup is roughly in line with history.
ATM IV
0.3%
30d HV
15.9%
Cross-company pattern from 30 similar setups.
Prior-quarter beat + options rich in Materials
Fade rate: 8 of 22 (36%)
This setup has occurred 30 times across Materials in the last 2 years. 14 of 22 (64%) held or extended their move within 5 days — this setup typically holds direction. The average absolute 1-day move is 2.9%, with a raw directional average of -0.4% (modestly negative historical bias).
Smart-money positioning from the most recent 13F filings.
Institutional
93.79%
of float
Insider
0.49%
of float
Holders
560
institutions
Top Holders· as of Jun 2026
Blackrock Inc.
4,964,479 sh · $826.1M
15.57%
2.5%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Balchem beats expectations, history suggests a positive stock reaction, with an average 1-day move of +1.51%.
In line / cautious
If results are in line with expectations, the stock may experience muted movement as investors await further commentary.
Miss
A miss could lead to a decline, with historical data indicating an average 1-day move of +0.73% when expectations are not met.
House and Senate STOCK Act disclosures over the trailing 6 months.
Trades
1
1 buy·0 sells
Members
1
House only
Est. Notional
$1,001.00–$15,000.00
disclosed dollar ranges
Most Active Members
1 trade
The lines on the call that would change the story.
Vanguard Portfolio Management LLC
2,221,267 sh · $369.6M
6.97%
1.3%
Vanguard Capital Management LLC
1,445,369 sh · $240.5M
4.53%
0.9%
State Street Corporation
1,281,552 sh · $213.3M
4.02%
3.3%
Geode Capital Management, LLC
1,122,146 sh · $186.7M
3.52%
7.2%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.
Net buying
Recent Transactions
Traded Jul 10, 2026 · disclosed Sep 4, 2026
$1,001.00–$15,000.00
Filed 30–45+ days after the trade. Treat as positional context, not a leading indicator. Amounts are SEC-mandated dollar ranges, not exact values.